These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18192900)

  • 1. A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation.
    Frey UH; Hauner H; Jöckel KH; Manthey I; Brockmeyer N; Siffert W
    Pharmacogenet Genomics; 2008 Feb; 18(2):141-51. PubMed ID: 18192900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional GNAS promoter polymorphism is associated with altered weight loss during short-term fasting.
    Frey UH; Michalsen A; Merse S; Dobos GJ; Siffert W
    Eur J Med Res; 2008 Dec; 13(12):576-8. PubMed ID: 19073398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel functional haplotype in the human GNAS gene alters Galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance.
    Frey UH; Adamzik M; Kottenberg-Assenmacher E; Jakob H; Manthey I; Broecker-Preuss M; Bergmann L; Heusch G; Siffert W; Peters J; Leineweber K
    Eur Heart J; 2009 Jun; 30(11):1402-10. PubMed ID: 19136681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice maintain predominantly maternal Gαs expression throughout life in brown fat tissue (BAT), but not other tissues.
    Tafaj O; Hann S; Ayturk U; Warman ML; Jüppner H
    Bone; 2017 Oct; 103():177-187. PubMed ID: 28694163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene.
    Germain-Lee EL; Schwindinger W; Crane JL; Zewdu R; Zweifel LS; Wand G; Huso DL; Saji M; Ringel MD; Levine MA
    Endocrinology; 2005 Nov; 146(11):4697-709. PubMed ID: 16099856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS A-1121G variant is associated with improved diastolic dysfunction in response to exercise training in heart failure patients.
    Alves AJ; Goldhammer E; Ribeiro F; Eynon N; Ben-Zaken Cohen S; Duarte JA; Viana JL; Sagiv M; Oliveira J
    Int J Sports Med; 2013 Mar; 34(3):274-80. PubMed ID: 23065660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for genetic linkage between a polymorphism in the GNAS gene and malaria in South Indian population.
    Gupta H; Sakharwade SC; Angural A; Kotambail A; Bhat GK; Hande MH; D'Souza SC; Rao P; Kumari V; Saadi AV; Satyamoorthy K
    Acta Trop; 2013 Dec; 128(3):571-7. PubMed ID: 23962387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interactions in the β-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study.
    Frey UH; Kottenberg E; Kamler M; Leineweber K; Manthey I; Heusch G; Siffert W; Peters J
    Br J Anaesth; 2011 Dec; 107(6):869-78. PubMed ID: 22088871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus.
    Li T; Vu TH; Zeng ZL; Nguyen BT; Hayward BE; Bonthron DT; Hu JF; Hoffman AR
    Genomics; 2000 Nov; 69(3):295-304. PubMed ID: 11056047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance.
    Mariot V; Maupetit-Méhouas S; Sinding C; Kottler ML; Linglart A
    J Clin Endocrinol Metab; 2008 Mar; 93(3):661-5. PubMed ID: 18182455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of the genotype in the GNAS Fok I polymorphism and prostate cancer.
    Eisenhardt A; Scherag A; Jöckel KH; Reis H; Rübben H; Siffert W
    Urol Int; 2011; 87(1):80-6. PubMed ID: 21677417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB.
    Liu J; Nealon JG; Weinstein LS
    Hum Mol Genet; 2005 Jan; 14(1):95-102. PubMed ID: 15537666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
    Jüppner H; Linglart A; Fröhlich LF; Bastepe M
    Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
    Frey UH; Lümmen G; Jäger T; Jöckel KH; Schmid KW; Rübben H; Müller N; Siffert W; Eisenhardt A
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):759-63. PubMed ID: 16467086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.
    Frey UH; Muehlschlegel JD; Ochterbeck C; Fox AA; Shernan SK; Collard CD; Lichtner P; Peters J; Body S
    Anesthesiology; 2014 May; 120(5):1109-1117. PubMed ID: 24755784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.
    Frey UH; Nückel H; Sellmann L; Siemer D; Küppers R; Dürig J; Dührsen U; Siffert W
    Clin Cancer Res; 2006 Oct; 12(19):5686-92. PubMed ID: 17020971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.